These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6147806)

  • 21. Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapy.
    Spaeth GL; Bernstein P; Caprioli J; Schiffman RM
    Am J Ophthalmol; 2011 Jan; 151(1):93-99.e4. PubMed ID: 21111399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension.
    Goñi FJ;
    Eur J Ophthalmol; 2005; 15(5):581-90. PubMed ID: 16167288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dopamine agonists and antagonists on pulsatile blood flow of ocular hypertensive rabbits.
    Hong SJ; Chiou GC
    J Ocul Pharmacol; 1993; 9(2):117-24. PubMed ID: 8102175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
    Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
    Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of single glaucoma medication in combined latanoprost and timolol XE therapy in patients with open-angle glaucoma and ocular hypertension: a discontinuation study.
    Kobayashi H
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):387-91. PubMed ID: 22335426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of the dorzolamide/timolol fixed combination versus latanoprost in the treatment of ocular hypertension or glaucoma: combined analysis of pooled data from two large randomized observer and patient-masked studies.
    Fechtner RD; McCarroll KA; Lines CR; Adamsons IA
    J Ocul Pharmacol Ther; 2005 Jun; 21(3):242-9. PubMed ID: 15969642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of dorzolamide–timolol (COSOPT) in patients who were treatment naive for open-angle glaucoma or ocular hypertension: the COSOPT first-line study.
    Crichton AC; Harasymowycz P; Hutnik CM; Behki R; Boucher S; Ibrahim F; Rifkind AW; Solomon L; Liao C; Bastien NR; Sampalis JS
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):503-11. PubMed ID: 20874498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oculohypotensive effects of foeniculum vulgare in experimental models of glaucoma.
    Agarwal R; Gupta SK; Agrawal SS; Srivastava S; Saxena R
    Indian J Physiol Pharmacol; 2008; 52(1):77-83. PubMed ID: 18831355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects.
    Huang SF; Chen JL; Yeh MK; Chiang CH
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):445-53. PubMed ID: 16386086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pressure or progression?
    Burnstein Y; Robin AL
    Arch Ophthalmol; 1999 Mar; 117(3):417-9. PubMed ID: 10088833
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.
    Vareilles P; Silverstone D; Plazonnet B; Le Douarec JC; Sears ML; Stone CA
    Invest Ophthalmol Vis Sci; 1977 Nov; 16(11):987-96. PubMed ID: 21145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaninolol: a novel compound for the treatment of glaucoma and ischemic retinopathy.
    Wu BN; Hong SJ; Sheu MM; Chen IJ; Liu SX; Chiou GC
    J Ocul Pharmacol Ther; 1995; 11(3):213-20. PubMed ID: 8590252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New furoxan derivatives for the treatment of ocular hypertension.
    Blangetti M; Rolando B; Chegaev K; Guglielmo S; Lazzarato L; Durante M; Masini E; Almirante N; Bastia E; Impagnatiello F; Fruttero R; Gasco A
    Bioorg Med Chem Lett; 2017 Feb; 27(3):479-483. PubMed ID: 28027869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
    Holló G; Kóthy P
    Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
    Liu JH; Medeiros FA; Slight JR; Weinreb RN
    Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.